335 related articles for article (PubMed ID: 16670069)
1. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy.
Santagostino E; Mancuso ME; Morfini M; Schiavoni M; Tagliaferri A; Barillari G; Mannucci PM
Haematologica; 2006 May; 91(5):634-9. PubMed ID: 16670069
[TBL] [Abstract][Full Text] [Related]
2. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
de Alarcon P; Benjamin R; Dugdale M; Kessler C; Shopnick R; Smith P; Abshire T; Hambleton J; Matthew P; Ortiz I; Cohen A; Konkle BA; Streiff M; Lee M; Wages D; Corash L
Transfusion; 2005 Aug; 45(8):1362-72. PubMed ID: 16078927
[TBL] [Abstract][Full Text] [Related]
3. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
White B; Lawler P; Riddell A; Nitu-Whalley IC; Hermans C; Lee CA; Brown SA
Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739
[TBL] [Abstract][Full Text] [Related]
4. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management.
Peyvandi F; Palla R; Menegatti M; Mannucci PM
Semin Thromb Hemost; 2009 Jun; 35(4):349-55. PubMed ID: 19598063
[TBL] [Abstract][Full Text] [Related]
5. Inherited bleeding disorders: a 14-year retrospective study.
Eid SS; Kamal NR; Shubeilat TS; Wael AG
Clin Lab Sci; 2008; 21(4):210-4. PubMed ID: 19174980
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of inherited coagulation disorders.
Escobar MA
Haemophilia; 2013 Sep; 19(5):648-59. PubMed ID: 23600951
[TBL] [Abstract][Full Text] [Related]
7. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
[TBL] [Abstract][Full Text] [Related]
8. Clinical audit of inherited bleeding disorders in a developing country.
Sajid R; Khalid S; Mazari N; Azhar WB; Khurshid M
Indian J Pathol Microbiol; 2010; 53(1):50-3. PubMed ID: 20090222
[TBL] [Abstract][Full Text] [Related]
9. Factor deficiencies in pregnancy.
Pike GN; Bolton-Maggs PH
Hematol Oncol Clin North Am; 2011 Apr; 25(2):359-78, viii-ix. PubMed ID: 21444035
[TBL] [Abstract][Full Text] [Related]
10. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
Björkman S; Folkesson A; Berntorp E
Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
[TBL] [Abstract][Full Text] [Related]
11. Rare bleeding disorders.
Peyvandi F; Kaufman RJ; Seligsohn U; Salomon O; Bolton-Maggs PH; Spreafico M; Menegatti M; Palla R; Siboni S; Mannucci PM
Haemophilia; 2006 Jul; 12 Suppl 3():137-42. PubMed ID: 16684009
[TBL] [Abstract][Full Text] [Related]
12. Management of orthopaedic surgery in rare bleeding disorders.
Siboni SM; Biguzzi E; Pasta G; Mannucci PM; Mistretta C; Fantini NN; Solimeno LP; Peyvandi F
Haemophilia; 2014 Sep; 20(5):693-701. PubMed ID: 24612427
[TBL] [Abstract][Full Text] [Related]
13. The obstetric experience of women with factor XI deficiency.
Chi C; Kulkarni A; Lee CA; Kadir RA
Acta Obstet Gynecol Scand; 2009; 88(10):1095-100. PubMed ID: 19685354
[TBL] [Abstract][Full Text] [Related]
14. Combined Factor V and Factor VIII Deficiency.
Spreafico M; Peyvandi F
Semin Thromb Hemost; 2009 Jun; 35(4):390-9. PubMed ID: 19598067
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrate.
Hernandez-Navarro F; Quintana M; Jimenez-Yuste V; Alvarez MT; Fernandez-Morata R
Haemophilia; 2008 Sep; 14(5):963-7. PubMed ID: 18624696
[TBL] [Abstract][Full Text] [Related]
16. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
Giansily-Blaizot M; Verdier R; Biron-Adréani C; Schved JF; Bertrand MA; Borg JY; Le Cam-Duchez V; Briquel ME; Chambost H; Pouymayou K; Dutrillaux F; Favier R; Martin-Toutain I; Verdy E; Gay V; Goudemand J; Navarro R; Durin A; d'Oiron R; Lambert T; Pernod G; Barrot C; Peynet J; Bastenaire B; Sie P; Stieltjes N; Torchet MF; de Moerloose P;
Haematologica; 2004 Jun; 89(6):704-9. PubMed ID: 15194538
[TBL] [Abstract][Full Text] [Related]
17. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
[TBL] [Abstract][Full Text] [Related]
19. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India.
Viswabandya A; Baidya S; Nair SC; Abraham A; George B; Mathews V; Chandy M; Srivastava A
Haemophilia; 2012 May; 18(3):e195-200. PubMed ID: 22221743
[TBL] [Abstract][Full Text] [Related]
20. Lack of bleeding in patients with severe factor VII deficiency.
Barnett JM; Demel KC; Mega AE; Butera JN; Sweeney JD
Am J Hematol; 2005 Feb; 78(2):134-7. PubMed ID: 15682417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
